S-equol shifts afatinib-altered mucosal immune–epithelial defense indices toward baseline and attenuates increases in DEFA5 and SOX9 promoter methylation indices

Immunology Letters · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles